Observed 30-day mortality rates of ICH in allo-HSCT patients by risk group in the derivation and external validation cohorts
| Risk group . | LAWS score . | Derivation cohort (n = 70) . | External validation (n = 36) . | All patients (N = 106) . |
|---|---|---|---|---|
| Low | 0-3 | 7/43 (16.3%) | 4/16 (25.0%) | 11/59 (18.6%) |
| Intermediate | 5-6 | 7/15 (46.7%) | 10/14 (71.4%) | 17/29 (58.6%) |
| High | 8-11 | 11/12 (91.7%) | 6/6 (100.0%) | 17/18 (94.4%) |
| Risk group . | LAWS score . | Derivation cohort (n = 70) . | External validation (n = 36) . | All patients (N = 106) . |
|---|---|---|---|---|
| Low | 0-3 | 7/43 (16.3%) | 4/16 (25.0%) | 11/59 (18.6%) |
| Intermediate | 5-6 | 7/15 (46.7%) | 10/14 (71.4%) | 17/29 (58.6%) |
| High | 8-11 | 11/12 (91.7%) | 6/6 (100.0%) | 17/18 (94.4%) |
Data are number of patients who died/total number of patients within each LAWS risk group (%).